17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study

DB Nelson, DD McIntire, J McDonald, J Gard… - American journal of …, 2017 - Elsevier
Background 17-alpha Hydroxyprogesterone caproate for prevention of recurrent preterm
birth is recommended for use in the United States. Objective We sought to assess the clinical
effectiveness of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth≤
35 weeks compared to similar births in our obstetric population prior to the implementation of
17-alpha hydroxyprogesterone caproate. Study Design This was a prospective cohort study
of 17-alpha hydroxyprogesterone caproate in our obstetric population. The primary outcome …